Generic-Drug Co. Concedes Infringement In Pfizer Heart Med Row

By Andrew Karpan (January 26, 2024, 9:57 PM EST) -- An Israeli drugmaker trying to market a generic version of one of Pfizer's historically more expensive brands of heart medication has agreed to limit its legal fight with the U.S. pharmaceutical giant to whether Pfizer's patents covering the drug will hold up in Delaware federal court....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!